Skip to main content
Fig. 2 | The Journal of Headache and Pain

Fig. 2

From: Persistent effectiveness of CGRP antibody therapy in migraine and comorbid medication overuse or medication overuse headache - a retrospective real-world analysis

Fig. 2

Treatment response up to 12 months. Development of MHD, MMD and AMD before and during treatment for EM with and without MO (a) and CM with and without MOH (b) up to 12 months. The number below shows the analysed patients at the respective time point. (AMD: monthly acute drug intake, MHD: monthly headache days, MMD: monthly migraine days, MO: medication overuse, MOH: medication overuse headache)

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us